At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
VERA Vera Therapeutics, Inc.
Closed Mourning Day 01-08 16:00:00 EST
42.19
+0.09
+0.21%
盘后42.19
+0.000.00%
17:48 EST
High42.23
Low40.80
Vol403.11K
Open41.89
D1 Closing42.10
Amplitude3.39%
Mkt Cap2.67B
Tradable Cap2.17B
Total Shares63.32M
T/O16.84M
T/O Rate0.78%
Tradable Shares51.45M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
BRIEF-Whp Global Agreement To Acquire Ip Of Vera Wang Fashion Brand
Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with immunoglobulin A nephropathy; and for treatment of lupus nephritis. It is also developing MAU868, a monoclonal antibody for the treatment of BK viremia infections. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California.